Banner

Revisiting the management of recurrent implantation failure through freeze-all policy

• 2017
Back
Publication Information
Authors Yasmin Magdi, M.Sc.,a Ahmed El-Damen, M.Sc.,b Ahmed Mohamed Fathi, M.Sc.,c Ahmed Mostafa Abdelaziz, M.D.,d Mohamed Abd-Elfatah Youssef, M.D., Ph.D.,e Ahmed Abd-Elmaged Abd-Allah, M.D.,e Mona Ahmed Elawady, M.D.,f Mohamed Ahmed Ibrahim, M.D.,d and Yehia
Keywords Freeze all policy, recurrent implantation failure
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
To determine whether a freeze-all policy for in vitro human blastocysts improves the ongoing pregnancy rate in patients
with recurrent implantation failure (RIF).
Design: Prospective cohort study.
Setting: Single private center.
Patient(s): A total of 171 women with RIF divided into two groups: freeze-all policy group (n ¼ 81) and fresh embryo transfer (ET)
group (n ¼ 90).
Intervention(s): Freeze-all policy.
Main Outcome Measure(s): Ongoing pregnancy rate.
Result(s): The clinical pregnancy rate (52% vs. 28%; odds ratio [OR] 1.86; 95% confidence interval [CI], 1.29–2.68) and ongoing
pregnancy rate (44% vs. 20%; OR 2.2; 95% CI, 1.04–3.45) were statistically significantly higher in the freeze-all group than the
fresh ET group, respectively. The implantation rate was also statistically significant (freeze-all group 44.2% vs. fresh ET group
15.8%; OR 2.80; 95% CI, 2.00–3.92).
Conclusion(s): The freeze-all policy statistically significantly improved the ongoing pregnancy and implantation rates. Thus, a freezeall
policy is likely to be the new key to helping open the black box of RIF. These findings also are useful for further investigating the
adverse effect of controlled ovarian stimulation on in vitro fertilization outcomes. (Fertil Steril 2017;-:-–-. 2017 by American
Society for Reproductive Medicine.)